Stability of trimedoxime in concentrated acidic injectable solutions

Military Medicine

Volumn 164, Issue 1, 1999, Pages 55-58

  Rubnov, Shai ^a   Amisar, Shai ^a   Levy, Daniel ^a   Muchtar, Shaul ^a   Schneider, Hava ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CITRATE SODIUM; CITRIC ACID; TRIMEDOXIME;

ARTICLE; DRUG DEGRADATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG HYDROLYSIS; DRUG STABILITY; DRUG STORAGE; PH; TEMPERATURE;

EID: 0345628586     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.1093/milmed/164.1.55     Document Type: Article

References (14)

1. Erdmann WD, Engelhard H: Pharmakologisch-toxicologiche Untersuchungen mit dem dichlorid des bis-(4-hydroxyiminomethyl-pyridlnium-(1)-methyl) athers, einem neuen esterase-reaktivator. Arzneim Forsch 1964; 14: 5-11.
2. Erdmann WD, Clarman M: Ein neuer esterase aktivator fur die behandlung von vergiftungen mit alkylphosphaten. Dtsch Med Wochenschr 1963; 45: 2201-6.
3. Luznjikov EA, Pankov AG: Iskustvo primenenia reaktivatora holinesterazy pri akutnom otravlenii organofosfornimy soedineniamy [translation from Russian]. Klin Med 1969; 7: 134-6.
4. Grob D, Johns RJ: Final Summary. Chemical Corps contract report DA 18-108-CML-5611, August 1958.
5. Flescher JH, Michel HO, Yates L, Harrison CS: 1,1′-Trimethylene bis(4-formylpyridinium bromide) dioxime (TMB-4) and 2-pyridine aldoxime methiodide (2-PAM) as adjuvants to atropine in the treatment of anticholinesterase poisoning. J Pharmacol Exp Ther 1960; 129: 31-5.
6. Heilbronn E, Tolagen B: Toxogonin in sarin, soman and tabun poisoning. Biochem Pharmacol 1965; 14: 73-7.
7. Hobbiger F, Vojvodic V: The reactivating and antidotal actions of TMB-4 and toxogonin with particular reference to their effect on phosphorylated acetylcholinesterase in the brain. Biochem Pharmacol 1966; 15: 1677-90.
8. Hobbiger F, Vojvodic V: The reactivation by pyridinium aldoximes of phosphorylated acetylcholinesterase in the central nervous system. Biochem Pharmacol 1967; 16: 455-62.
9. Ellin RI, Easterday DE, Zvirblis P, Kondritzer AA: Kinetics of deterioration of trimethylenebis(4-formylpyridinium bromide) dioxime in dilute aqueous solutions. J Pharm Sci 1966; 55: 1263-7.
10. Christenson I: Hydrolysis of bis(4-hydroxyiminomethyl-1-pyridiniomethyl)ether dichloride (Toxogonin®). I. Decomposition products. Acta Pharm Suec 1968; 5: 23-36.
11. Christenson I: Hydrolysis of bis(4-hydroxyiminomethyl-1-pyridiniomethyl)ether dichloride (Toxogonin®). II. Kinetics and equilibrium in acidic solution. Acta Pharm Suec 1968; 5: 249-62.
12. Ellin RI, Carlease JS, Kondritzer AA: Stability of pyridine-2-aldoxime methiodide. II. Kinetics of deterioration in dilute aqueous solutions. J Pharm Sci 1962; 51: 141-6.
13. Christenson I: Stability of the nerve gas antidote bis(4-hydroxyiminomethyl-1-pyridiniomethyl)ether dichloride (Toxogonin®). Drug Intell 1968; 2: 234-43.
14. Kassel LS: Kinetics of homogeneous gas reactions. ACS Monogr 1932; 57: 150.